InVitria's Cellastim improves cell growth

USA-based InVitria's Cellastim cell culture supplements optimized cell growth and productivity of hybridoma cells in serveral recent studies  published in the Bioprocessing Journal.

Additional findings from the study showed that Cellastim improved the  cell growth and productivity in long-term culture. In a 25-day period,  cell doublings in Cellastim-supplemented media were twice that of media  without the agent. Also, antibody production was 65% higher in the  commercial media with Cellastim while cells supplemented with Cellastim  grew to higher density than those in unsupplemented media.

"This research supports what customers have been reporting from their  use of Cellastim for hybridoma cell culture," said chief executive Scott  Deeter. "Cellastim has been shown to not only optimize hybridoma  performance, but also outperform other sources of native and recombinant  albumin," he added.